220 related articles for article (PubMed ID: 23684830)
1. Cutaneous vaccination: antigen delivery into or onto the skin.
Weniger BG; Glenn GM
Vaccine; 2013 Jul; 31(34):3389-91. PubMed ID: 23684830
[No Abstract] [Full Text] [Related]
2. Delivery systems for intradermal vaccination.
Kim YC; Jarrahian C; Zehrung D; Mitragotri S; Prausnitz MR
Curr Top Microbiol Immunol; 2012; 351():77-112. PubMed ID: 21472533
[TBL] [Abstract][Full Text] [Related]
3. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
[TBL] [Abstract][Full Text] [Related]
5. Hollow microneedle-mediated intradermal delivery of model vaccine antigen-loaded PLGA nanoparticles elicits protective T cell-mediated immunity to an intracellular bacterium.
de Groot AM; Du G; Mönkäre J; Platteel ACM; Broere F; Bouwstra JA; Sijts AJAM
J Control Release; 2017 Nov; 266():27-35. PubMed ID: 28917531
[TBL] [Abstract][Full Text] [Related]
6. Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design.
Chen MC; Lai KY; Ling MH; Lin CW
Acta Biomater; 2018 Jan; 65():66-75. PubMed ID: 29109028
[TBL] [Abstract][Full Text] [Related]
7. Devices for intradermal vaccination.
Kis EE; Winter G; Myschik J
Vaccine; 2012 Jan; 30(3):523-38. PubMed ID: 22100637
[TBL] [Abstract][Full Text] [Related]
8. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
[TBL] [Abstract][Full Text] [Related]
9. Recent insights into cutaneous immunization: How to vaccinate via the skin.
Engelke L; Winter G; Hook S; Engert J
Vaccine; 2015 Sep; 33(37):4663-74. PubMed ID: 26006087
[TBL] [Abstract][Full Text] [Related]
10. Intradermal delivery for vaccine dose sparing: overview of current issues.
Zehrung D; Jarrahian C; Wales A
Vaccine; 2013 Jul; 31(34):3392-5. PubMed ID: 23176978
[TBL] [Abstract][Full Text] [Related]
11. Microneedles for transdermal drug delivery: a minireview.
Vandervoort J; Ludwig A
Front Biosci; 2008 Jan; 13():1711-5. PubMed ID: 17981662
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery.
Babiuk S; Baca-Estrada M; Babiuk LA; Ewen C; Foldvari M
J Control Release; 2000 May; 66(2-3):199-214. PubMed ID: 10742580
[TBL] [Abstract][Full Text] [Related]
13. Measles vaccination using a microneedle patch.
Edens C; Collins ML; Ayers J; Rota PA; Prausnitz MR
Vaccine; 2013 Jul; 31(34):3403-9. PubMed ID: 23044406
[TBL] [Abstract][Full Text] [Related]
14. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.
Al-Zahrani S; Zaric M; McCrudden C; Scott C; Kissenpfennig A; Donnelly RF
Expert Opin Drug Deliv; 2012 May; 9(5):541-50. PubMed ID: 22475249
[TBL] [Abstract][Full Text] [Related]
15. Microneedles for vaccine delivery: challenges and future perspectives.
Shin CI; Jeong SD; Rejinold NS; Kim YC
Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous vaccines--current and emerging strategies.
Hirobe S; Okada N; Nakagawa S
Expert Opin Drug Deliv; 2013 Apr; 10(4):485-98. PubMed ID: 23316778
[TBL] [Abstract][Full Text] [Related]
17. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
[TBL] [Abstract][Full Text] [Related]
18. Diphtheria toxoid dissolving microneedle vaccination: Adjuvant screening and effect of repeated-fractional dose administration.
Leone M; Romeijn S; Du G; Le Dévédec SE; Vrieling H; O'Mahony C; Bouwstra JA; Kersten G
Int J Pharm; 2020 Apr; 580():119182. PubMed ID: 32119899
[TBL] [Abstract][Full Text] [Related]
19. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination.
Chen MC; Huang SF; Lai KY; Ling MH
Biomaterials; 2013 Apr; 34(12):3077-86. PubMed ID: 23369214
[TBL] [Abstract][Full Text] [Related]
20. Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles.
Hsueh KJ; Chen MC; Cheng LT; Lee JW; Chung WB; Chu CY
Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():78-87. PubMed ID: 28131383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]